| Name | monoamine oxidase |
|---|---|
| Synonyms | Adrenalin oxidase; Amine oxidase; Amine oxidase [flavin containing] B; MAO B; MAOB; Monoamine oxidase; Monoamine oxidase B; Monoamine oxidase type B… |
| Name | TCA |
|---|---|
| CAS | 2,2,2-trichloroacetic acid |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 15553532 | Miller J: Managing antidepression overdoses. Emerg Med Serv. 2004 Oct;33(10):113-9. Although there are seven distinct classes of antidepressants, prehospital care professionals should at minimum be able to distinguish the monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), selective reuptake inhibitors (SSRIs), and newer antidepressants that are none of these. |
2(0,0,0,2) | Details |
| 15663788 | Berggard C, Damberg M, Oreland L: Brainstem levels of transcription factor AP-2 in rat are changed after treatment with phenelzine, but not with BMC Pharmacol. 2005 Jan 21;5:1. BACKGROUND: Before therapeutic effect is obtained after treatment with antidepressant drugs, like selective reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAO-Is) there is an initial lag-period of a few weeks. |
1(0,0,0,1) | Details |
| 19766953 | Nishtala PS, McLachlan AJ, Bell JS, Chen TF: Determinants of antidepressant medication prescribing in elderly residents of aged care homes in Australia: a retrospective study. Am J Geriatr Pharmacother. 2009 Aug;7(4):210-9. SSRIs were more commonly prescribed than TCAs, monoamine oxidase inhibitors, and other antidepressants. |
1(0,0,0,1) | Details |
| 15778882 | Feltenstein MW, Sufka KJ: Screening antidepressants in the chick separation-stress paradigm. Psychopharmacology. 2005 Aug;181(1):153-9. Epub 2005 Oct 15. OBJECTIVES: The purpose of the present research was to further validate the chick separation-stress paradigm as an animal model of anxiety by examining its sensitivity to the monoamine oxidase inhibitor (MAOI) phenelzine (6.25, 12.5, 25.0 mg/kg), the tricyclic antidepressant (TCA) (5.0, 10.0, 20.0 mg/kg), the selective reuptake inhibitor (SSRI) (1.0, 2.5, 5.0 mg/kg), and the reuptake inhibitor (NRI) maprotiline (5.0, 10.0, 20.0 mg/kg) under acute (no pretreatment) or repeated (3 or 6 days pretreatment) administration procedures. |
1(0,0,0,1) | Details |
| 20191898 | Zamosteanu N, Filip C, Jerca L, Albut I, Cuciureanu R: Biogenic amines determination in some Romanian meat products. . Rev Med Chir Soc Med Nat Iasi. 2009 Oct-Dec;113(4):1195-9. CONCLUSIONS: Our study indicates the presence of biogenic amines in Romanian meat products and signals to the risk of food consumption, for persons which are allergic or for those under classical monoamine-oxidase inhibitor drug therapy. |
1(0,0,0,1) | Details |
| 12943557 | Damberg M, Berggard C, Oreland L: Phenelzine treatment increases transcription factor AP-2 levels in rat brain. BMC Pharmacol. 2003 Aug 28;3:10. Epub 2003 Aug 28. We have also reported an association between a specific genotype of AP-2beta to personality traits, binge-eating disorder and platelet monoamine oxidase (MAO) activity. |
1(0,0,0,1) | Details |
| 14994733 | Alexopoulos GS, Streim J, Carpenter D, Docherty JP: Using antipsychotic agents in older patients. J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. In combining antidepressants and antipsychotics, the experts would be much more cautious with selective reuptake inhibitors that are more potent inhibitors of the CYP 450 enzymes (i.e., fluoxetine, fluvoxamine, paroxetine) and with nefazodone, TCAs, and monoamine oxidase inhibitors. |
1(0,0,0,1) | Details |
| 12495364 | De Lima MS, Hotopf M: Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence. Drug Saf. 2003;26(1):55-64. Regarding placebo-controlled trials (n = 16), similar results were obtained in terms of efficacy for different groups of drugs, such as tricyclic antidepressants (TCAs), selective reuptake inhibitors (SSRIs), monoamine oxidase inhibitors (MAOIs) and other drugs (sulpiride, amineptine, and ritanserin). |
1(0,0,0,1) | Details |
| 18761333 | Heydendael W, Jacobson L: Differential effects of and phenelzine on corticosteroid receptor gene expression in mouse brain: potential relevance to antidepressant response. Brain Res. 2008 Oct 31;1238:93-107. Epub 2008 Aug 16. Because monoamine oxidase inhibitors (MAOI) are often more effective than tricyclic antidepressants (TCA) for atypical depression, we hypothesized that to normalize HPA function in atypical depression, MAOI would differ from TCA in decreasing rather than increasing feedback sensitivity. |
1(0,0,0,1) | Details |
| 16229049 | Mayers AG, Baldwin DS: Antidepressants and their effect on sleep. Hum Psychopharmacol. 2005 Dec;20(8):533-59. Insomnia is often seen with monoamine oxidase inhibitors (MAOIs), with all tricyclic antidepressants (TCAs) except amitriptyline, and all selective reuptake inhibitors (SSRIs) with and moclobemide as well. |
1(0,0,0,1) | Details |
| 17640153 | Thase ME: Recognition and diagnosis of atypical depression. . J Clin Psychiatry. 2007;68 Suppl 8:11-6. The term atypical depression dates to the first wave of reports describing differential response to monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs). |
1(0,0,0,1) | Details |
| 20077058 | Winecker RE: Quantification of antidepressants using gas chromatography-mass spectrometry. Methods Mol Biol. 2010;603:45-56. These are monoamine oxidase inhibitors (MAOI), cyclic antidepressants including tricyclic and tetracyclic compounds (TCA), selective reuptake inhibitors (SSRI), - reuptake inhibitors (SNRI), and atypical compounds. |
31(0,1,1,1) | Details |